{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T05:07:01Z","timestamp":1768626421955,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,29]]},"DOI":"10.7759\/cureus.70442","type":"journal-article","created":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T15:36:33Z","timestamp":1727624193000},"source":"Crossref","is-referenced-by-count":2,"title":["Carnitine Palmitoyltransferase II (CPT2) Deficiency: An Overlooked and Elusive Cause of Acute Kidney Injury"],"prefix":"10.7759","author":[{"given":"Saimir","family":"Seferi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Saliaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriola","family":"Likaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merita","family":"Rroji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15698\/cst2020.01.209","article-title":"Fatty acids - from energy substrates to key regulators of cell survival, proliferation and effector function","volume":"4","author":"Cucchi D","year":"2019","unstructured":"Cucchi D, Camacho-Mu\u00f1oz D, Certo M, Pucino V, Nicolaou A, Mauro C. Fatty acids - from energy substrates to key regulators of cell survival, proliferation and effector function. Cell Stress. 2019, 4:9-23. 10.15698\/cst2020.01.209","journal-title":"Cell Stress"},{"key":"ref2","article-title":"Biochemistry, fatty acid oxidation","author":"Talley JT","year":"2024","unstructured":"Talley JT, Mohiuddin SS. Biochemistry, fatty acid oxidation. StatPearls. StatPearls Publishing, Treasure Island, Fl; 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-0035-1","article-title":"Structural insight into function and regulation of carnitine palmitoyltransferase","volume":"66","author":"Rufer AC","year":"2009","unstructured":"Rufer AC, Thoma R, Hennig M. Structural insight into function and regulation of carnitine palmitoyltransferase. Cell Mol Life Sci. 2009, 66:2489-501. 10.1007\/s00018-009-0035-1","journal-title":"Cell Mol Life Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010082","article-title":"Muscle carnitine palmitoyltransferase II deficiency: a review of enzymatic controversy and clinical features","volume":"18","author":"Lehmann D","year":"2017","unstructured":"Lehmann D, Motlagh L, Robaa D, Zierz S. Muscle carnitine palmitoyltransferase II deficiency: a review of enzymatic controversy and clinical features. Int J Mol Sci. 2017, 18:82. 10.3390\/ijms18010082","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25081784","article-title":"Muscle carnitine palmitoyltransferase II (CPT II) deficiency: a conceptual approach","volume":"25","author":"Joshi PR","year":"2020","unstructured":"Joshi PR, Zierz S. Muscle carnitine palmitoyltransferase II (CPT II) deficiency: a conceptual approach. Molecules. 2020, 25:10.3390\/molecules25081784","journal-title":"Molecules"},{"key":"ref6","unstructured":"Carnitine palmitoyltransferase II deficiency. (2010). Accessed. September 24, 2024: https:\/\/www.orpha.net\/en\/disease\/detail\/157#:~:text=Carnitine%20palmitoyltransferase%20II%20(CPT%20II)%20deficiency%2...."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","author":"Palmisano BT","year":"2017","unstructured":"Palmisano BT, Zhu L, Stafford JM. Role of estrogens in the regulation of liver lipid metabolism. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Mauvais-Jarvis F (ed): Springer, Cham; 2017. 227-56. 10.1007\/978-3-319-70178-3_12"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46595","article-title":"Myopathic carnitine palmitoyltransferase II (CPT II) deficiency: a rare cause of acute kidney injury and cardiomyopathy","volume":"15","author":"Castillo E","year":"2023","unstructured":"Castillo E, Medina D, Schoenmann N. Myopathic carnitine palmitoyltransferase II (CPT II) deficiency: a rare cause of acute kidney injury and cardiomyopathy. Cureus. 2023, 15:e46595. 10.7759\/cureus.46595","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-023-00804-8","article-title":"Adult-onset carnitine palmitoyl transferase II (CPT II) deficiency presenting with rhabdomyolysis and acute kidney injury","volume":"13","author":"Akar HT","year":"2024","unstructured":"Akar HT, Y\u0131ld\u0131z Y, Mutluay R, Tekin E, Tokatl\u0131 A. Adult-onset carnitine palmitoyl transferase II (CPT II) deficiency presenting with rhabdomyolysis and acute kidney injury. CEN Case Rep. 2024, 13:81-5. 10.1007\/s13730-023-00804-8","journal-title":"CEN Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00497","article-title":"Unrecognized high occurrence of genetically confirmed hereditary carnitine palmitoyltransferase II deficiency in an Austrian family points to the ongoing underdiagnosis of the disease","volume":"10","author":"Zach C","year":"2019","unstructured":"Zach C, Unterkofler K, Fraunberger P, Drexel H, Muendlein A. Unrecognized high occurrence of genetically confirmed hereditary carnitine palmitoyltransferase II deficiency in an Austrian family points to the ongoing underdiagnosis of the disease. Front Genet. 2019, 10:497. 10.3389\/fgene.2019.00497","journal-title":"Front Genet"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.3889\/oamjms.2018.158","article-title":"Carnitine palmitoyltransferase II deficiency (CPT II) followed by rhabdomyolysis and acute kidney injury","volume":"6","author":"Gjorgjievski N","year":"2018","unstructured":"Gjorgjievski N, Dzekova-Vidimliski P, Petronijevic Z, Selim G, Dejanov P, Tozija L, Sikole A. Carnitine palmitoyltransferase II deficiency (CPT II) followed by rhabdomyolysis and acute kidney injury. Open Access Maced J Med Sci. 2018, 6:666-8.","journal-title":"Open Access Maced J Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijns7030055","article-title":"Detection of early onset carnitine palmitoyltransferase II deficiency by newborn screening: should CPT II deficiency be a primary disease target?","volume":"7","author":"Mador-House R","year":"2021","unstructured":"Mador-House R, Liu Z, Dyack S. Detection of early onset carnitine palmitoyltransferase II deficiency by newborn screening: should CPT II deficiency be a primary disease target?. Int J Neonatal Screen. 2021, 7:10.3390\/ijns7030055","journal-title":"Int J Neonatal Screen"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1751143719889766","article-title":"Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: a case report and systematic review of the literature","volume":"21","author":"Ivin N","year":"2020","unstructured":"Ivin N, Della Torre V, Sanders F, Youngman M. Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: a case report and systematic review of the literature. J Intensive Care Soc. 2020, 21:165-73. 10.1177\/1751143719889766","journal-title":"J Intensive Care Soc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","author":"Deschauer M","year":"2005","unstructured":"Deschauer M, Wieser T, Zierz S. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol. 2005, 62:37-41. 10.1001\/archneur.62.1.37","journal-title":"Arch Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<210::AID-HUMU5>3.0.CO;2-0","article-title":"Novel mutations associated with carnitine palmitoyltransferase II deficiency","volume":"13","author":"Taggart RT","year":"1999","unstructured":"Taggart RT, Smail D, Apolito C, Vladutiu GD. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum Mutat. 1999, 13:210-20. 10.1002\/(SICI)1098-1004(1999)13:3&lt;210::AID-HUMU5&gt;3.0.CO;2-0","journal-title":"Hum Mutat"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.12.026","article-title":"Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients","volume":"338","author":"Joshi PR","year":"2014","unstructured":"Joshi PR, Deschauer M, Zierz S. Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients. J Neurol Sci. 2014, 338:107-11. 10.1016\/j.jns.2013.12.026","journal-title":"J Neurol Sci"},{"key":"ref17","unstructured":"Emergency guidelines. Accessed. September 24, 2024: https:\/\/www.bimdg.org.uk\/guidelines\/guidelines-adult.asp."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.704290","article-title":"Exercise, nutrition, and supplements in the muscle carnitine palmitoyl-transferase II deficiency: new theoretical bases for potential applications","volume":"12","author":"Negro M","year":"2021","unstructured":"Negro M, Cerullo G, Parimbelli M, et al.. Exercise, nutrition, and supplements in the muscle carnitine palmitoyl-transferase II deficiency: new theoretical bases for potential applications. Front Physiol. 2021, 12:704290. 10.3389\/fphys.2021.704290","journal-title":"Front Physiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/163173","article-title":"Fenofibrate therapy in carnitine palmitoyl transferase type 2 deficiency","volume":"2012","author":"Hamilton-Craig I","year":"2012","unstructured":"Hamilton-Craig I, Yudi M, Johnson L, Jayasinghe R. Fenofibrate therapy in carnitine palmitoyl transferase type 2 deficiency. Case Rep Med. 2012, 2012:163173. 10.1155\/2012\/163173","journal-title":"Case Rep Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278685-carnitine-palmitoyltransferase-ii-cpt2-deficiency-an-overlooked-and-elusive-cause-of-acute-kidney-injury","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T15:36:35Z","timestamp":1727624195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278685-carnitine-palmitoyltransferase-ii-cpt2-deficiency-an-overlooked-and-elusive-cause-of-acute-kidney-injury"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,29]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.70442","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,29]]}}}